Breaking News

  • 9 hours ago

  • Vaibhavi M.

Japan Grants First Global Approval To Chugai’s Lunsumio–Polivy Combination For Relapsed Large B-Cell Lymphoma
Breaking News

More News

Theriva Secures FDA Agreement On Phase 3 Trial Design For VCN-01 In Metastatic Pancreatic Cancer

Theriva Secures FDA Agreement On Phase 3 Trial Design For VCN-01 In Me...

Vaibhavi M.

Oryzon Secures U.S. Patent for Iadademstat–Venetoclax Combination Therapies In Acute Myeloid Leukaemia, Strengthening Global Oncology IP

Oryzon Secures U.S. Patent for Iadademstat–Venetoclax Combination Ther...

Vaibhavi M.

Tarsus Secures $15 Million Milestone As China Approves TP-03 Eye Therapy Through Grand Pharma Partnership

Tarsus Secures $15 Million Milestone As China Approves TP-03 Eye Thera...

Vaibhavi M.

Pfizer And Valneva Report Strong Phase 3 Efficacy For Investigational Lyme Disease Vaccine, Plan Regulatory Submissions

Pfizer And Valneva Report Strong Phase 3 Efficacy For Investigational ...

Vaibhavi M.

Ad
Advertisement
Ad
Advertisement
Pharma Now

Weekly Pharma insights directly in your inbox

Get most important news delivered to your email inbox

Pharma Now

Weekly Pharma insights directly in your inbox

Get most important news delivered to your email inbox

Ad
Advertisement